Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 19717)

Published in Proc Natl Acad Sci U S A on March 17, 1998

Authors

L L Hampton1, E E Ladenheim, M Akeson, J M Way, H C Weber, V E Sutliff, R T Jensen, L J Wine, H Arnheiter, J F Battey

Author Affiliations

1: Laboratory of Molecular Biology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD 20850, USA.

Articles citing this

International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev (2007) 2.50

Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell (2011) 2.13

The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest (1999) 1.45

Itch signaling in the nervous system. Physiology (Bethesda) (2011) 1.13

Chronic itch development in sensory neurons requires BRAF signaling pathways. J Clin Invest (2013) 1.13

Behavioral actions of alcohol: phenotypic relations from multivariate analysis of mutant mouse data. Genes Brain Behav (2012) 1.00

Laser-capture microdissection and transcriptional profiling of the dorsomedial nucleus of the hypothalamus. J Comp Neurol (2012) 0.95

Investigating endogenous peptides and peptidases using peptidomics. Biochemistry (2011) 0.91

Cross-inhibition of NMBR and GRPR signaling maintains normal histaminergic itch transmission. J Neurosci (2014) 0.90

Insights into bombesin receptors and ligands: Highlighting recent advances. Peptides (2015) 0.85

Double homozygous waltzer and Ames waltzer mice provide no evidence of retinal degeneration. Mol Vis (2008) 0.84

Gastrin-releasing peptide receptors in the central nervous system: role in brain function and as a drug target. Front Endocrinol (Lausanne) (2012) 0.81

Descending control of itch transmission by the serotonergic system via 5-HT1A-facilitated GRP-GRPR signaling. Neuron (2014) 0.81

Gastrin-releasing peptide signaling plays a limited and subtle role in amygdala physiology and aversive memory. PLoS One (2012) 0.78

New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer. Br J Cancer (2016) 0.78

Feeding and the rhodopsin family g-protein coupled receptors in nematodes and arthropods. Front Endocrinol (Lausanne) (2012) 0.76

Signal transduction of bombesin-induced circular smooth muscle cell contraction in cat esophagus. World J Gastroenterol (2006) 0.76

Molecular cloning and characterization of avian bombesin-like peptide receptors: new tools for investigating molecular basis for ligand selectivity. Br J Pharmacol (2003) 0.75

Articles cited by this

Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell (1991) 14.23

Evolution of genetic redundancy. Nature (1997) 4.95

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature (1985) 4.47

Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia (1971) 3.15

Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. Proc Natl Acad Sci U S A (1983) 3.09

Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16

Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature (1997) 1.79

Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc Natl Acad Sci U S A (1991) 1.75

Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord. Biochem Biophys Res Commun (1983) 1.61

Effect of intravenous human gastrin-releasing peptide on food intake in humans. Gastroenterology (1994) 1.48

BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J Biol Chem (1993) 1.47

Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas. J Biol Chem (1982) 1.37

cDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor. Neuron (1991) 1.29

Bombesin suppresses feeding in rats. Nature (1979) 1.28

Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor. Mol Endocrinol (1990) 1.22

Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. Am J Physiol (1989) 1.10

Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy. Eur J Biochem (1992) 1.01

Potent bombesin receptor antagonists distinguish receptor subtypes. Am J Physiol (1990) 0.94

Distribution of bombesin binding sites in the rat gastrointestinal tract. Peptides (1988) 0.92

Effects of bombesin on behavior. Life Sci (1985) 0.91

Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes. Mol Pharmacol (1993) 0.91

Interaction of bombesin and related peptides with receptors on pancreatic acinar cells. Ann N Y Acad Sci (1988) 0.89

Expression of bombesin-receptor subtypes and their differential regulation of colonic smooth muscle contraction. Gastroenterology (1993) 0.88

A rhesus monkey model to characterize the role of gastrin-releasing peptide (GRP) in lung development. Evidence for stimulation of airway growth. J Clin Invest (1994) 0.87

Comparison of gene expression for two distinct bombesin receptor subtypes in postnatal rat central nervous system. Mol Cell Neurosci (1992) 0.86

The actions of bombesin-like peptides on food intake. Ann N Y Acad Sci (1988) 0.85

Microstructural analysis of licking behavior following peripheral administration of bombesin or gastrin-releasing peptide. Peptides (1995) 0.82

A novel bombesin receptor antagonist selectively blocks the satiety action of peripherally administered bombesin. Pharmacol Biochem Behav (1994) 0.82

Receptor subtype mediation of feeding suppression by bombesin-like peptides. Pharmacol Biochem Behav (1996) 0.81

Intravenous infusion of bombesin reduces food intake in humans. Am J Physiol (1993) 0.81

Characterization of the bombesin receptor on mouse pancreatic acini by chemical cross-linking. Peptides (1991) 0.80

Bombesin Receptor Gene Expression in Rat Embryos: Transient GRP-R Gene Expression in the Posterior Pituitary. Mol Cell Neurosci (1993) 0.78

Characterization of bombesin binding sites in the rat stomach. Eur J Pharmacol (1997) 0.78

Articles by these authors

Rapid discrimination among individual DNA hairpin molecules at single-nucleotide resolution using an ion channel. Nat Biotechnol (2001) 6.07

Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell (1993) 5.00

microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev (1994) 3.44

Putative mammalian taste receptors: a class of taste-specific GPCRs with distinct topographic selectivity. Cell (1999) 3.40

Measles virus P gene codes for two proteins. J Virol (1985) 3.31

Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein. J Virol (1983) 3.30

Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med (1999) 3.21

Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet (1994) 2.97

Host gene influences sensitivity to interferon action selectively for influenza virus. Nature (1980) 2.88

Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med (1996) 2.51

International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev (2007) 2.50

Role of the nucleocapsid protein in regulating vesicular stomatitis virus RNA synthesis. Cell (1985) 2.38

Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum Genet (2000) 2.34

Adult mouse hepatocytes in primary monolayer culture express genetic resistance to mouse hepatitis virus type 3. J Immunol (1982) 2.32

Nanopores and nucleic acids: prospects for ultrarapid sequencing. Trends Biotechnol (2000) 2.25

N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts. Mol Cell Biol (1990) 2.24

Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med (1979) 2.14

Identification of a novel member of the T1R family of putative taste receptors. J Neurochem (2001) 2.11

Vesicular stomatitis virus N and NS proteins form multiple complexes. J Virol (1986) 2.01

Human small-cell lung cancers show amplification and expression of the N-myc gene. Proc Natl Acad Sci U S A (1986) 1.96

Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach. Ann Intern Med (1993) 1.94

Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. J Nucl Med (1999) 1.92

Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore) (2000) 1.88

Signaling and transcriptional regulation in early mammalian eye development: a link between FGF and MITF. Development (2000) 1.87

Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proc Natl Acad Sci U S A (1992) 1.85

The Hox-1.3 homeo box protein is a sequence-specific DNA-binding phosphoprotein. Genes Dev (1989) 1.83

Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study. Ann Intern Med (1989) 1.78

Localization and surgical treatment of occult insulinomas. Ann Surg (1990) 1.76

Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc Natl Acad Sci U S A (1991) 1.75

Primary structure of alpha 2-macroglobulin receptor-associated protein. Human homologue of a Heymann nephritis antigen. J Biol Chem (1991) 1.74

Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study. Ann Surg (1992) 1.71

Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. Development (1997) 1.69

Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology (1990) 1.68

Stereo images of vesicular stomatitis virus assembly. J Virol (1986) 1.63

Transport of the murine Mx protein into the nucleus is dependent on a basic carboxy-terminal sequence. J Interferon Res (1987) 1.62

Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy (2010) 1.60

Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol (1999) 1.59

Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Dig Dis Sci (1989) 1.57

Gastrinomas: localization by means of selective intraarterial injection of secretin. Radiology (1990) 1.56

Expression of influenza virus NS2 nonstructural protein in bacteria and localization of NS2 in infected eucaryotic cells. J Virol (1985) 1.55

Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Cancer (1999) 1.52

Activity of rat Mx proteins against a rhabdovirus. J Virol (1990) 1.52

New DNA sequencing methods. Annu Rev Biomed Eng (2001) 1.49

Characteristics of cell lines established from human gastric carcinoma. Cancer Res (1990) 1.49

Use of omeprazole in patients with Zollinger-Ellison syndrome. Dig Dis Sci (1991) 1.49

Mutations in microphthalmia, the mouse homolog of the human deafness gene MITF, affect neuroepithelial and neural crest-derived melanocytes differently. Mech Dev (1998) 1.49

Mutations of ESPN cause autosomal recessive deafness and vestibular dysfunction. J Med Genet (2004) 1.48

Direct visualization of protein transport and processing in the living cell by microinjection of specific antibodies. Cell (1984) 1.48

BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J Biol Chem (1993) 1.47

Mapping and characterization of a novel cochlear gene in human and in mouse: a positional candidate gene for a deafness disorder, DFNA9. Genomics (1997) 1.46

A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. Am J Physiol Regul Integr Comp Physiol (2001) 1.45

Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Ann Surg (1986) 1.44

Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: interactions between KIT and MITF. Development (2000) 1.43

Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosomes Cancer (1998) 1.43

Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci U S A (1980) 1.43

Virus-induced autoantibody response to a transgenic viral antigen. Nature (1990) 1.42

Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome. Ann Surg (1998) 1.42

Zollinger-Ellison syndrome: current concepts and management. Ann Intern Med (1983) 1.42

Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. Cancer Res (1998) 1.40

Central leptin modulates behavioral and neural responsivity to CCK. Am J Physiol (1999) 1.39

News from the National Institute on Deafness and Other Communication Disorders. Am J Otol (1998) 1.39

Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas. J Biol Chem (1982) 1.37

Genetically determined resistance to infection by hepatotropic influenza A virus in mice: effect of immunosuppression. Infect Immun (1976) 1.35

Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors. J Biol Chem (1997) 1.33

Expression of interferon dependent resistance to influenza virus in mouse embryo cells. Arch Virol (1983) 1.31

Ethanol consumption and serotonin-1A (5-HT1A) receptor function in heterozygous BDNF (+/-) mice. J Neurochem (2003) 1.31

Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci U S A (1978) 1.30

Regulation of chlorophyll apoprotein expression and accumulation. Requirements for carotenoids and chlorophyll. J Biol Chem (1992) 1.28

The recessive phenotype displayed by a dominant negative microphthalmia-associated transcription factor mutant is a result of impaired nucleation potential. Mol Cell Biol (1996) 1.28

The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay. Brain Res (1981) 1.27

Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation. Ann Surg (1988) 1.27

Constitutive achlorhydria in mucolipidosis type IV. Proc Natl Acad Sci U S A (1998) 1.26

Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci U S A (1992) 1.26

A synthetic peptide that is a bombesin receptor antagonist. Nature (1984) 1.24

Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus. J Exp Med (1981) 1.24

Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera. N Engl J Med (1985) 1.24

Host gene influence on interferon action in adult mouse hepatocytes: specificity for influenza virus. Virology (1980) 1.23

Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3. Hum Mol Genet (1994) 1.23

Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. Clin Cancer Res (1999) 1.23

Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. J Biol Chem (1991) 1.23

Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. Gastroenterology (1997) 1.23

Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. Am J Med (1998) 1.22

Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg (1994) 1.21

Studies of the interferon receptors. Pharmacol Ther (1984) 1.21

Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase. Dev Biol (2001) 1.21

Human interferon alpha enters cells by receptor-mediated endocytosis. Virology (1983) 1.20

Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management. J Clin Oncol (1998) 1.20

Perturbation and change in coral reef communities. Proc Natl Acad Sci U S A (1982) 1.20

CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones. Am J Physiol (1999) 1.19

Detection of duodenal gastrinomas by operative endoscopic transillumination. A prospective study. Gastroenterology (1990) 1.18

A general method to design dominant negatives to B-HLHZip proteins that abolish DNA binding. Proc Natl Acad Sci U S A (1997) 1.15

Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med (1998) 1.15